• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Bracco takes control of Acist

Article

Italian pharmaceutical maker Bracco has completed its acquisition of Acist, a start-up that manufactures contrast media injection systems. Bracco previously had a 12% stake in Acist, whose latest generation of injectors allows the automatic and

Italian pharmaceutical maker Bracco has completed its acquisition of Acist, a start-up that manufactures contrast media injection systems. Bracco previously had a 12% stake in Acist, whose latest generation of injectors allows the automatic and controlled administration of fluids during x-ray procedures. Acist has more than 500 systems installed worldwide and a 50% share of the U.S. cardiology injector market.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.